Centro de Imagem Diagnósticos S.A (AALR3) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Centro de Imagem Diagnósticos S.A (AALR3) has a cash flow conversion efficiency ratio of 0.071x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (R$78.10 Million ≈ $15.32 Million USD) by net assets (R$1.10 Billion ≈ $215.70 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Check AALR3 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Centro de Imagem Diagnósticos S.A - Cash Flow Conversion Efficiency Trend (2010–2024)
This chart illustrates how Centro de Imagem Diagnósticos S.A's cash flow conversion efficiency has evolved over time, based on yearly financial data. See AALR3 net asset value for net asset value and shareholders' equity analysis.
Centro de Imagem Diagnósticos S.A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Centro de Imagem Diagnósticos S.A ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Darya-Varia Laboratoria Tbk
JK:DVLA
|
0.063x |
|
Singha Estate Public Company Limited
BK:S
|
0.022x |
|
Nava Nakorn Public Company Limited
BK:NNCL
|
-0.053x |
|
FPX Nickel Corp
V:FPX
|
-0.011x |
|
Bionet
TWO:1784
|
0.013x |
|
Wellspire Holdings Berhad
KLSE:0271
|
-0.129x |
|
Alcidion Group Ltd
AU:ALC
|
0.113x |
|
Cypherpunk Technologies Inc.
NASDAQ:CYPH
|
-0.043x |
Annual Cash Flow Conversion Efficiency for Centro de Imagem Diagnósticos S.A (2010–2024)
The table below shows the annual cash flow conversion efficiency of Centro de Imagem Diagnósticos S.A from 2010 to 2024. For the full company profile with market capitalisation and key ratios, see Centro de Imagem Diagnósticos S.A (AALR3) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | R$1.14 Billion ≈ $223.06 Million |
R$-41.02 Million ≈ $-8.05 Million |
-0.036x | -133.30% |
| 2023-12-31 | R$943.99 Million ≈ $185.23 Million |
R$102.30 Million ≈ $20.07 Million |
0.108x | -43.19% |
| 2022-12-31 | R$981.92 Million ≈ $192.67 Million |
R$187.30 Million ≈ $36.75 Million |
0.191x | +54.70% |
| 2021-12-31 | R$1.21 Billion ≈ $237.31 Million |
R$149.13 Million ≈ $29.26 Million |
0.123x | +28.02% |
| 2020-12-31 | R$1.22 Billion ≈ $240.11 Million |
R$117.86 Million ≈ $23.13 Million |
0.096x | -40.42% |
| 2019-12-31 | R$1.32 Billion ≈ $259.01 Million |
R$213.41 Million ≈ $41.87 Million |
0.162x | +30.36% |
| 2018-12-31 | R$1.30 Billion ≈ $255.03 Million |
R$161.19 Million ≈ $31.63 Million |
0.124x | +17.39% |
| 2017-12-31 | R$1.27 Billion ≈ $249.25 Million |
R$134.19 Million ≈ $26.33 Million |
0.106x | +62.12% |
| 2016-12-31 | R$1.21 Billion ≈ $237.80 Million |
R$78.97 Million ≈ $15.50 Million |
0.065x | -51.54% |
| 2015-12-31 | R$733.00 Million ≈ $143.83 Million |
R$98.56 Million ≈ $19.34 Million |
0.134x | +109.55% |
| 2014-12-31 | R$743.32 Million ≈ $145.85 Million |
R$47.69 Million ≈ $9.36 Million |
0.064x | +4.79% |
| 2013-12-31 | R$279.49 Million ≈ $54.84 Million |
R$17.11 Million ≈ $3.36 Million |
0.061x | -63.19% |
| 2012-12-31 | R$234.93 Million ≈ $46.10 Million |
R$39.07 Million ≈ $7.67 Million |
0.166x | +29.64% |
| 2011-12-31 | R$257.14 Million ≈ $50.46 Million |
R$32.99 Million ≈ $6.47 Million |
0.128x | -58.17% |
| 2010-12-31 | R$35.66 Million ≈ $7.00 Million |
R$10.94 Million ≈ $2.15 Million |
0.307x | -- |
About Centro de Imagem Diagnósticos S.A
Alliança Saúde e Participações S.A. provides diagnostic imaging and medicine services in Brazil. The company offers diagnostic imaging, clinical analysis, nuclear medicine, genetic testing, and vaccination services, as well as corporate, remote, and in-person solutions for hospitals and diagnostic centers in the private and public sectors. It provides clinical analysis services, such as blood cou… Read more